azacitidine has been researched along with Cardiac Remodeling, Ventricular in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahn, Y; Hong, MH; Jeong, HC; Jeong, HY; Jeong, MH; Kang, WS; Kim, YS; Kwon, JS | 1 |
| Baugh, J; Corrigan, N; Glezeva, N; Horgan, S; Ledwidge, M; McDonald, K; Neary, R; Tea, I; Watson, CJ | 1 |
| Cao, F; Fan, W; Liang, D; Pei, X; Qin, X; Sun, D; Wang, S; Wang, Y; Xie, X | 1 |
3 other study(ies) available for azacitidine and Cardiac Remodeling, Ventricular
| Article | Year |
|---|---|
Protective role of 5-azacytidine on myocardial infarction is associated with modulation of macrophage phenotype and inhibition of fibrosis.
Topics: Animals; Antimetabolites, Antineoplastic; Azacitidine; Blotting, Western; Cells, Cultured; Fibroblasts; Fibrosis; Immunoenzyme Techniques; Macrophages; Male; Mice; Mice, Inbred BALB C; Myocardial Infarction; Nitric Oxide; Nitric Oxide Synthase; Peptidoglycan; Phenotype; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Ventricular Dysfunction, Left; Ventricular Remodeling | 2014 |
Epigenetic Therapy for the Treatment of Hypertension-Induced Cardiac Hypertrophy and Fibrosis.
Topics: Actins; Animals; Azacitidine; Cardiomegaly; Carrier Proteins; Cells, Cultured; Collagen Type I; Collagen Type III; Disease Models, Animal; DNA Methylation; DNA Modification Methylases; Enzyme Inhibitors; Epigenesis, Genetic; Fibroblasts; Fibrosis; Gene Expression Regulation; Humans; Hypertension; Male; Myocytes, Cardiac; Rats, Inbred SHR; Rats, Inbred WKY; Transforming Growth Factor beta1; Ventricular Remodeling | 2016 |
Effects of hepatocyte growth factor overexpressed bone marrow-derived mesenchymal stem cells on prevention from left ventricular remodelling and functional improvement in infarcted rat hearts.
Topics: Animals; Azacitidine; Bone Marrow Cells; Cells, Cultured; Coronary Vessels; Disease Models, Animal; Female; Hemodynamics; Hepatocyte Growth Factor; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Myocardial Infarction; Neovascularization, Physiologic; Rats; Rats, Wistar; Transfection; Ventricular Remodeling | 2012 |